SUMMIT THERAPEUTICS PLC's ticker is SMMT and the CUSIP is 86627R102. A total of 14 filers reported holding SUMMIT THERAPEUTICS PLC in Q2 2017. The put-call ratio across all filers is - and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2020 | $355,000 | -23.5% | 119,570 | -38.9% | 0.00% | – |
| Q1 2020 | $464,000 | +24.1% | 195,619 | -16.3% | 0.00% | – |
| Q4 2019 | $374,000 | -8.3% | 233,778 | +2.6% | 0.00% | – |
| Q3 2019 | $408,000 | +32.0% | 227,960 | -6.7% | 0.00% | – |
| Q2 2019 | $309,000 | -25.9% | 244,201 | +7.1% | 0.00% | – |
| Q1 2019 | $417,000 | +59.2% | 227,956 | +0.0% | 0.00% | – |
| Q4 2018 | $262,000 | -48.3% | 227,912 | -0.1% | 0.00% | – |
| Q3 2018 | $507,000 | -9.3% | 228,207 | -0.0% | 0.00% | – |
| Q2 2018 | $559,000 | -81.1% | 228,232 | -0.4% | 0.00% | -100.0% |
| Q1 2018 | $2,956,000 | +286.4% | 229,142 | +231.9% | 0.00% | – |
| Q4 2017 | $765,000 | +329.8% | 69,039 | +413.6% | 0.00% | – |
| Q1 2017 | $178,000 | +161.8% | 13,442 | +68.0% | 0.00% | – |
| Q4 2016 | $68,000 | +3300.0% | 8,000 | +3100.0% | 0.00% | – |
| Q3 2016 | $2,000 | – | 250 | +4066.7% | 0.00% | – |
| Q1 2016 | $0 | – | 6 | -14.3% | 0.00% | – |
| Q4 2015 | $0 | – | 7 | -22.2% | 0.00% | – |
| Q3 2015 | $0 | – | 9 | +12.5% | 0.00% | – |
| Q2 2015 | $0 | – | 8 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Worth Asset Management, LLC | 10,956 | $20,488 | 0.02% |
| Lindbrook Capital, LLC | 782 | $1,462 | 0.00% |